Auckland District MEC/07/02/027 Approve Watch and Wait Dr Leanne Berkahn Intervention Health Board Auckland District MEC/07/06/086 Approve Taxus Perseus Dr John Ormiston Intervention Health Board The ALLG (Australasian MEC/07/10/132 Approve Leukaemia & Lymphoma Group) Professor Peter John Browett Intervention CML9/TIDEL II Study VIEW-primary and secondary MEC/07/19/EXP Approve Ms T Riddell Intervention care PREDICT CVD cohort MEC/07/76/EXP Approve BCCA Associate Professor Ian Bissett Intervention Invalid MEC/07/76/EXP BCCA Dr Andrew Hunter Intervention Application MEC/08/01/008 Approve Dr Melinda Nolan Intervention Protocol No. 3133K1-3000-WW or MEC/08/03/028 Approve Dr Philip Wood Intervention Protocol No. 3133K1-3001-WW Mary-Anne MEC/08/05/055 Approve Professor Edward Gane Intervention Woodnorth ANBL0531 Response and Auckland District MEC/08/06/072 Approve Biology-Based Therapy for Dr Lochie Teague Intervention Health Board Intermediate Risk Neuroblastoma. MEC/08/07/081 Approve SUCCEED Dr David Porter Intervention MEC/08/09/110 Approve OSA Interfaces Ms Cheung Intervention First Study Protocol Number: Auckland District MEC/08/10/123 Approve 07-01 Professor Peter John Browett Intervention Health Board (Celgene) A clinical to test the benefit of MEC/08/10/133 Approve recMAGE-A3 + AS15ASCI in Dr Mike McCrystal Intervention patients with malignant melanoma A clinical trial to test the benefit of Invalid MEC/08/10/133 recMAGE-A3 + AS15ASCI in Ms Sherry Nisbet Intervention Application patients with malignant melanoma
MEC/07/02/027 Approve Watch and Wait Dr Leanne Berkahn Auckland District Health Board Intervention MEC/07/06/086 Approve Taxus Perseus Dr John Ormiston Auckland District Health Board Intervention MEC/07/10/132 Approve The ALLG (Australasian Leukaemia & Lymphoma Group) CML9/TIDEL II Study Professor Peter John Browett Intervention MEC/07/19/EXP Approve VIEW-primary and secondary care PREDICT CVD cohort Ms T Riddell Intervention MEC/07/76/EXP Approve BCCA Associate Professor Ian Bissett Intervention MEC/07/76/EXP Invalid Application BCCA Dr Andrew Hunter Intervention MEC/08/01/008 Approve Dr Melinda Nolan Intervention MEC/08/03/028 Approve Protocol No. 3133K1-3000-WW or Protocol No. 3133K1-3001-WW Dr Philip Wood Intervention MEC/08/05/055 Approve Professor Edward Gane Mary-Anne Woodnorth Intervention MEC/08/06/072 Approve ANBL0531 Response and Biology-Based Therapy for Intermediate Risk Neuroblastoma. Dr Lochie Teague Auckland District Health Board Intervention MEC/08/07/081 Approve SUCCEED Dr David Porter Intervention MEC/08/09/110 Approve OSA Interfaces Ms Cheung Intervention MEC/08/10/123 Approve First Study Protocol Number: 07-01 (Celgene) Professor Peter John Browett Auckland District Health Board Intervention MEC/08/10/133 Approve A clinical to test the benefit of recMAGE-A3 + AS15ASCI in patients with malignant melanoma Dr Mike McCrystal Intervention MEC/08/10/133 Invalid Application A clinical trial to test the benefit of recMAGE-A3 + AS15ASCI in patients with malignant melanoma Ms Sherry Nisbet Intervention
northern-a-ethics-committee-annual-report-2013.docx